The 7th biennial Pharmaceutical Flow Cytometry and Imaging meeting will be held at GlaxoSmithKline, Stevenage, UK. Flow cytometry and imaging are two powerful technology platforms that enable high-content analysis of physiologically-relevant cell systems and pre-clinical and clinical biomarkers. Since the first meeting in 2008, the technology has developed and the applications widened across many areas of industrial and academic drug discovery and development.
This meeting will focus on the application of Flow Cytometry and Imaging to illuminate biology from the single cell to the patient. The scientific program for this meeting is:
- Translational Flow Cytometry and Imaging in Drug Discovery and Development: Application of technology in biological models from the microscale and single cell through to complex in-vitro tissue systems and the clinic.
- Novel and Emerging Technologies: Next generation instrumentation, and probe and sensor technology for pharmaceutical research.
- Drug discovery in the era of Multi-omics and spatial cytometry: Exploration of the latest multi-parameter techniques and the analytical challenges of using multi-omics approaches to link the genome and proteome to cellular regulation and function.
It aims to bring together the research community working in the field of flow cytometry and imaging with interests in developing and applying the technology for pharmaceutical research. Join scientists from pharma, biotech, CROs and academia to hear talks given by speakers at the cutting edge of cytometry, take part in commercial vendor lab-based workshops, network at the exhibition, innovation forum and speakers dinner and gain strategic insights into solutions for increasing the success of drug discovery and development.